AU2000265109A1 - Method and compositions for prevention and/or treatment of diabetes and glucose modulation - Google Patents
Method and compositions for prevention and/or treatment of diabetes and glucose modulationInfo
- Publication number
- AU2000265109A1 AU2000265109A1 AU2000265109A AU6510900A AU2000265109A1 AU 2000265109 A1 AU2000265109 A1 AU 2000265109A1 AU 2000265109 A AU2000265109 A AU 2000265109A AU 6510900 A AU6510900 A AU 6510900A AU 2000265109 A1 AU2000265109 A1 AU 2000265109A1
- Authority
- AU
- Australia
- Prior art keywords
- diabetes
- prevention
- compositions
- treatment
- glucose modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/021050 WO2002009693A1 (en) | 2000-08-02 | 2000-08-02 | Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000265109A1 true AU2000265109A1 (en) | 2002-02-13 |
Family
ID=21741654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000265109A Abandoned AU2000265109A1 (en) | 2000-08-02 | 2000-08-02 | Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1305018A4 (en) |
JP (1) | JP2004505042A (en) |
AU (1) | AU2000265109A1 (en) |
WO (1) | WO2002009693A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1665566A (en) | 2000-09-21 | 2005-09-07 | 营养21公司 | Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
EP1302114A3 (en) * | 2001-10-16 | 2004-01-14 | Loders Croklaan B.V. | Mixtures for stimulating glucose up-take |
WO2005083070A1 (en) * | 2004-03-01 | 2005-09-09 | Pharmadesign, Inc. | Pharmaceutical composition for lowering blood sugar level |
US7666447B2 (en) | 2004-10-08 | 2010-02-23 | Pharmanutrients | Compositions including Krill extracts and conjugated linoleic acid and methods of using same |
WO2008018147A1 (en) | 2006-08-11 | 2008-02-14 | Kao Corporation | Fat or oil composition |
US8809560B2 (en) | 2011-05-17 | 2014-08-19 | Board Of Trustees Of The University Of Arkansas | Trans-, trans-conjugated linoleic acid compositions and use thereof |
ES2395529B1 (en) * | 2011-06-08 | 2014-04-11 | Pri, S.A. | SYNERGIC COMBINATION FOR THE TREATMENT OF MELLITUS DIABETES TYPE 2. |
US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
US9062276B2 (en) | 2012-12-03 | 2015-06-23 | Board Of Trustees Of The University Of Arkansas | Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis |
CN103190611A (en) * | 2013-03-17 | 2013-07-10 | 王伟 | Chrysanthemum capsules with blood sugar reducing function and preparation method thereof |
EP3038474A4 (en) * | 2013-08-26 | 2017-03-08 | Charles H. Liu | Nutraceutical combination for prevention and treatment of type 2 diabetes |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
EP3050023B1 (en) | 2014-10-27 | 2021-08-25 | Aseko, Inc. | Subcutaneous outpatient management |
CA2993275C (en) | 2015-08-20 | 2022-06-21 | Aseko, Inc. | Diabetes management therapy advisor |
CN107243043A (en) * | 2017-08-17 | 2017-10-13 | 刘明州 | A kind of Chinese medicine treated diabetes and control its complication to occur |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3783206T2 (en) * | 1986-10-27 | 1993-05-27 | Abbott Lab | LIQUID NUTRITION TABLE FOR GLUCOSE INTOLERANCE. |
US5976548A (en) * | 1994-11-08 | 1999-11-02 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
US5730988A (en) * | 1995-04-20 | 1998-03-24 | Lynntech, Inc. | Nutritional supplements for improving glucose metabolism |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
IT1291113B1 (en) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS |
DE69832520T2 (en) * | 1997-12-12 | 2006-08-10 | Purdue Research Foundation, West Lafayette | USE OF CONJUGATED LINOLEIC ACID FOR THE TREATMENT OF TYPE II DIABETES |
AU5802499A (en) * | 1998-09-01 | 2000-03-21 | Amway Corporation | Diet composition and method of weight management |
-
2000
- 2000-08-02 JP JP2002515246A patent/JP2004505042A/en active Pending
- 2000-08-02 WO PCT/US2000/021050 patent/WO2002009693A1/en not_active Application Discontinuation
- 2000-08-02 AU AU2000265109A patent/AU2000265109A1/en not_active Abandoned
- 2000-08-02 EP EP00952402A patent/EP1305018A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2004505042A (en) | 2004-02-19 |
EP1305018A4 (en) | 2006-08-30 |
EP1305018A1 (en) | 2003-05-02 |
WO2002009693A1 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000265109A1 (en) | Method and compositions for prevention and/or treatment of diabetes and glucose modulation | |
AUPR638101A0 (en) | Composition and method for treatment of disease | |
HK1172504A1 (en) | Composition and methods for modulation of vascular structure and or function | |
AU2002241228A1 (en) | Method and composition for treatment of skeletal dysplasias | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
AU2003257937A1 (en) | Methods and compositions for treatment of dermal conditions | |
AU2197100A (en) | Treatment of tooth surfaces and substance therefor | |
AU6872498A (en) | Method and composition for skin treatment | |
AU1450900A (en) | Methods of treatment of type 2 diabetes | |
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
AU2002231095A1 (en) | Method and composition for the treatment of diabetic neuropathy | |
WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
AU7061200A (en) | Compositions and method for treatment of acetaminophen intoxication | |
AU1794801A (en) | Method for treatment and prevention of physiological shock | |
PL348049A1 (en) | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications | |
AU2003231279A1 (en) | Prevention and treatment of type 2 diabetes | |
AU2420101A (en) | Method and composition for the treatment of pain | |
AU2001273759A1 (en) | Essential oils and chemically related species for the treatment of increased bone resorption | |
AU2001262177A1 (en) | Method of treatment | |
AU2002230509A1 (en) | Devices and methods for treating low blood sugar levels | |
HUP0203676A3 (en) | Pharmaceutical composition and method for treatment of diabetes | |
AU4598400A (en) | Method of treatment | |
AU2002322862A1 (en) | Methods and compositions for diagnosis and treatment of vascular conditions | |
AU2382601A (en) | Novel method of treatment | |
AU6622600A (en) | Low concentration pest treatment composition and method |